These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35368120)

  • 1. Magnetic resonance imaging metrics and the predictability of adverse outcomes in on-treatment Asian chronic hepatitis B.
    Hui RW; Chiu KW; Mak LY; Chang HC; Cheung KS; Fung J; Yuen MF; Seto WK
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1139-1147. PubMed ID: 35368120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinoma.
    Hui RW; Chan AC; Lo G; Lo R; Chan C; Kotewall CN; Mak LY; She WH; Au KP; Ai V; Fung J; Yuen MF; Seto WK
    Hepatol Int; 2022 Apr; 16(2):371-380. PubMed ID: 35347596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.
    Imajo K; Tetlow L; Dennis A; Shumbayawonda E; Mouchti S; Kendall TJ; Fryer E; Yamanaka S; Honda Y; Kessoku T; Ogawa Y; Yoneda M; Saito S; Kelly C; Kelly MD; Banerjee R; Nakajima A
    World J Gastroenterol; 2021 Feb; 27(7):609-623. PubMed ID: 33642832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection.
    Mak LY; Hui RW; Fung J; Liu F; Wong DK; Li B; Cheung KS; Yuen MF; Seto WK
    Hepatol Int; 2021 Aug; 15(4):901-911. PubMed ID: 34152534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
    Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
    Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
    Lee SW; Huang DQ; Bettencourt R; Ajmera V; Tincopa M; Noureddin N; Amangurbanova M; Siddiqi H; Madamba E; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Yoneda M; Idilman R; Gumussoy M; Oz DK; Erden A; Loomba R
    Aliment Pharmacol Ther; 2024 Jan; 59(1):80-88. PubMed ID: 37968251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric ultrasound imaging for early-stage steatosis: Comparison with magnetic resonance imaging-based proton density fat fraction.
    Baek J; Basavarajappa L; Margolis R; Arthur L; Li J; Hoyt K; Parker KJ
    Med Phys; 2024 Feb; 51(2):1313-1325. PubMed ID: 37503961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
    Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
    J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MR assessment of liver fat, iron, and fibrosis: a concise overview of the liver "Triple Screen".
    Low G; Ferguson C; Locas S; Tu W; Manolea F; Sam M; Wilson MP
    Abdom Radiol (NY); 2023 Jun; 48(6):2060-2073. PubMed ID: 37041393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease.
    Jayaswal ANA; Levick C; Selvaraj EA; Dennis A; Booth JC; Collier J; Cobbold J; Tunnicliffe EM; Kelly M; Barnes E; Neubauer S; Banerjee R; Pavlides M
    Liver Int; 2020 Dec; 40(12):3071-3082. PubMed ID: 32730664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Fibrosis Staging with MR Elastography: Comparison of Diagnostic Performance between Patients with Chronic Hepatitis B and Those with Other Etiologic Causes.
    Chang W; Lee JM; Yoon JH; Han JK; Choi BI; Yoon JH; Lee KB; Lee KW; Yi NJ; Suh KS
    Radiology; 2016 Jul; 280(1):88-97. PubMed ID: 26844364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.
    Pavlides M; Banerjee R; Sellwood J; Kelly CJ; Robson MD; Booth JC; Collier J; Neubauer S; Barnes E
    J Hepatol; 2016 Feb; 64(2):308-315. PubMed ID: 26471505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-derived proton density fat fraction.
    Yoshizawa E; Yamada A
    J Med Ultrason (2001); 2021 Oct; 48(4):497-506. PubMed ID: 34669068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
    Jayakumar S; Middleton MS; Lawitz EJ; Mantry PS; Caldwell SH; Arnold H; Mae Diehl A; Ghalib R; Elkhashab M; Abdelmalek MF; Kowdley KV; Stephen Djedjos C; Xu R; Han L; Mani Subramanian G; Myers RP; Goodman ZD; Afdhal NH; Charlton MR; Sirlin CB; Loomba R
    J Hepatol; 2019 Jan; 70(1):133-141. PubMed ID: 30291868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis.
    Dennis A; Kelly MD; Fernandes C; Mouchti S; Fallowfield JA; Hirschfield G; Pavlides M; Harrison S; Chakravarthy MV; Banerjee R; Sanyal A
    Front Endocrinol (Lausanne); 2020; 11():575843. PubMed ID: 33584535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in enhanced liver fibrosis score and liver stiffness measurement reflects lower risk of hepatocellular carcinoma.
    Liang LY; Wong VW; Tse YK; Yip TC; Lui GC; Chan HL; Wong GL
    Aliment Pharmacol Ther; 2019 Jun; 49(12):1509-1517. PubMed ID: 31025388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy.
    Seo YS; Kim MN; Kim SU; Kim SG; Um SH; Han KH; Kim YS
    Medicine (Baltimore); 2016 Mar; 95(12):e2985. PubMed ID: 27015173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
    Zhang T; Zhang G; Deng X; Zeng J; Jin J; Zeping H; Wu M; Zheng R
    Radiology; 2021 Nov; 301(2):350-359. PubMed ID: 34427463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease.
    Schaapman JJ; Tushuizen ME; Coenraad MJ; Lamb HJ
    J Magn Reson Imaging; 2021 Jun; 53(6):1623-1631. PubMed ID: 32822095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.